Details of the Drug-Related molecule(s) Interaction Atlas

STK696827 Drug Info

CHEMBL1084866; 4-[2-(Anthracen-9-Ylmethylidene)hydrazino]-N-(3-Chlorophenyl)-4-Oxobutanamide; 4-[(2E)-2-(anthracen-9-ylmethylidene)hydrazinyl]-N-(3-chlorophenyl)-4-oxobutanamide; NadD inhibitor 1_02; SCHEMBL11887958; A0640/0029695; STK696827; BDBM50318652; AKOS001707409; US8785499, 1_02; 4-{2-[(E)-1-(9-anthryl)methylidene]hydrazino}-N-(3-chlorophenyl)-4-oxobutanamide; (E)-4-(2-(anthracen-9-ylmethylene)hydrazinyl)-N-(3-chlorophenyl)-4-oxobutanamide

Cross-matching ID

PubChem CID

9597188

TTD Drug ID

DM19GAY

General Information of Drug (ID: DM19GAY)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Bacterial Nicotinate-nucleotide adenylyltransferase (Bact nadD)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
DZ9	DM2HLGC	N. A.	N. A.	Patented	[1]
AC1LJNG0	DM9Q0EC	N. A.	N. A.	Patented	[1]
Nicotinamide-Adenine-Dinucleotide	DM9LRKB	N. A.	N. A.	Investigative	[2]
Deamido-NAD	DMDFRTI	N. A.	N. A.	Investigative	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Bacterial Nicotinate-nucleotide adenylyltransferase (Bact nadD)	TT1NFO3	NADD_ECOLI	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Targeting NAD biosynthesis in bacterial pathogens. US8785499.
2	How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
3	Crystal structures of E. coli nicotinate mononucleotide adenylyltransferase and its complex with deamido-NAD. Structure. 2002 Jan;10(1):69-79.